The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(20 sites)

China

Fujian Medical University Union Hospital, Fuzhou, Fujian

Guangzhou First People's Hospital, Guangzhou, Guangdong

Anyang City Tumor Hospital, Anyang, Henan

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan

The Affiliated Hospital of lnner Mongolia Medical University, Hohhot, Inner Mongolia

Suzhou Municipal Hospital, Suzhou, Jiangsu

Nanchang People's Hospital, Nanchang, Jiangxi

The First Hospital of Jilin University, Changchun, Jilin

Shanxi Bethune Hospital, Taiyuan, Shanxi

Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi

The Fourth People's Hospital of Sichuan Province, Chengdu, Sichuan

Chengdu Fifth People's Hospital, Chengdu, Sichuan

Sichuan Cancer Hospital, Chengdu, Sichuan

West China hospital of Sichuan University, Chengdu, Sichuan

West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan

West China Tianfu Hospital, Chengdu, Sichuan

Deyang People's Hospital, Deyang, Sichuan

Mianyang Hospital of Traditional Chinese Medicine, Mianyang, Sichuan

The People's Hospital of Dazu, Chongqing, Chongqing